Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended April 30, 2009, for Mountain West Business Solutions, Inc. (Note: The input metadata referenced "Sunshine Biopharma Inc.", but the filing text explicitly identifies the registrant as Mountain West Business Solutions, Inc.). The company is a development-stage entity incorporated in Colorado in August 2006, focused on providing management consulting services regarding accounting, computer, and general business issues to small and home-office based companies. As of the reporting date, the company had no active operations and was in the process of developing its business plan.
Key Financial Metrics
| Metric | Q1 2009 (3 Months) | YTD 2009 (9 Months) | YTD 2008 (9 Months) |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Net Loss | $(5,879) | $(16,249) | $(25,474) |
| General & Administrative Expenses | $2,470 | $10,460 | $21,836 |
| Cash and Cash Equivalents (Ending) | $636 | $636 | $4,391 |
| Total Assets | $636 | $636 | $5,029 (July 31, 2008) |
| Total Liabilities | $34,595 | $34,595 | $22,739 (July 31, 2008) |
| Shareholders' Equity | $(33,959) | $(33,959) | $(17,710) (July 31, 2008) |
| Weighted Avg. Shares Outstanding | 9,388,000 | 9,388,000 | 9,388,000 |
Liquidity and Debt: The company reported a cash balance of only $636 as of April 30, 2009. Current liabilities totaled $34,595, primarily consisting of notes payable ($26,500), accounts payable ($6,280), and interest payable ($1,815). The company has a significant accumulated deficit of $60,476 since inception.
Material Changes vs. Prior Period
- Expense Reduction: General and administrative expenses decreased significantly from $21,836 in the nine months ended April 30, 2008, to $10,460 in the same period in 2009. This reduction was driven by lower legal fees ($0 vs. $7,500) and office expenses.
- Net Loss Improvement: The net loss for the nine months ended April 30, 2009, was $16,249, an improvement compared to the $25,474 loss in the prior year period.
- Cash Depletion: Cash and cash equivalents declined from $4,362 at the end of the previous fiscal year (July 31, 2008) to $636 at April 30, 2009. Net cash used in operating activities was $8,726 for the nine-month period.
- Debt Increase: Current portion of notes payable increased from $17,000 to $26,500, reflecting a $5,000 cash inflow from financing activities during the period.
Guidance, Outlook, and Risks
Management Commentary and Outlook: Management states that the company has no active operations and is currently developing its business plan. They anticipate overhead costs will remain constant as revenues develop and believe the company could be profitable by the end of fiscal year 2009 if sufficient revenues are generated. The company expects capital costs of approximately $10,000 to $12,000 over the next twelve months to expand operations.
Capital Resources: The company has no plans to raise additional funds within the next twelve months, relying instead on internal operations or loans from the President, Mr. Milonas, who has agreed to loan necessary funds through December 31, 2009. However, management acknowledges that additional resources will be needed to expand into additional locations.
Risks and Contingencies:
- Going Concern: Due to continued net losses and lack of operating history, accountants have expressed doubt about the company's ability to continue as a going concern.
- Lack of Revenue: The company has generated zero revenue since its inception in August 2006. There is no assurance that it will ever become profitable.
- Liquidity Risk: The company is minimally capitalized with only $636 in cash. Failure to generate sufficient revenues or secure additional financing could force the company to cease operations.
- Market Risk: The stock is quoted on the OTC Bulletin Board and is considered a "penny stock," subject to trading restrictions that may limit liquidity. Approximately 99% of outstanding shares are restricted from immediate resale.
- Competition: The company faces intense competition from larger, more established firms with greater financial resources.
Investor Verification Checklist
- Verify Company Identity: Confirm the registrant is Mountain West Business Solutions, Inc., not Sunshine Biopharma Inc. as suggested in the metadata.
- Cash Runway: Assess the viability of operations with only $636 in cash against $34,595 in current liabilities.
- Debt Obligations: Review the terms of the $26,500 in notes payable and the reliance on loans from the President.
- Revenue Generation: Investigate any new contracts or revenue streams, as the company has had zero revenue for over two years.
- Going Concern Status: Review the auditor's report in the most recent 10-K for the specific language regarding the "going concern" doubt.
- Stock Liquidity: Check current trading volume on the OTC Bulletin Board given the "penny stock" designation and restricted share status.